Resultado da Busca
David Earl Nichols (born December 23, 1944, Covington, Kentucky) is an American pharmacologist and medicinal chemist. Previously the Robert C. and Charlotte P. Anderson Distinguished Chair in Pharmacology at Purdue University, Nichols has worked in the field of psychoactive drugs since 1969.
2017. Effects of Schedule I drug laws on neuroscience research and treatment innovation. DJ Nutt, LA King, DE Nichols. Nature Reviews Neuroscience 14 (8), 577-585. , 2013. 392. 2013. Effects of enantiomers of MDA, MDMA and related analogues on [3H] serotonin and [3H] dopamine release from superfused rat brain slices.
Professor Emeritus of Pharmacology. E-mail: drdave@purdue.edu. Specialization: Medicinal and Bioorganic Chemistry; Molecular Pharmacology and Toxicology. Education. B.S. - 1969 - University of Cincinnati. Ph.D. - 1973 - University of Iowa. Postdoc - 1973-74 -University of Iowa. Research.
12 de jan. de 2024 · Dr. David E. Nichols is one of the world’s leading experts in the field of psychedelic pharmacology. He’s a Professor Emeritus of Pharmacology at Purdue University and the co-founder of the Heffter Research Institute.
- 1944-Present
- Pharmacology Professor
- American
The greatest living psychedelic chemist Dr. David E. Nichols tells the story of his life in research while synthesizing a novel lysergamideA big thank you fo...
- 243 min
- 75,2K
- Hamilton Morris
Psychedelics (serotonergic hallucinogens) are powerful psychoactive substances that alter perception and mood and affect numerous cognitive processes. They are generally considered physiologically safe and do not lead to dependence or addiction.
David E Nichols 1. Affiliation. 1 Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, 27599, USA. drdave@purdue.edu. PMID: 32398764. DOI: 10.1038/s41429-020-0311-8. Abstract. Psilocybin (4-phosphoryloxy-N,N-dimethyltryptamine) is an indole-based secondary metabolite produced by numerous species of mushrooms.
